{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05281237",
            "orgStudyIdInfo": {
                "id": "21-412"
            },
            "organization": {
                "fullName": "Beth Israel Deaconess Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "Avecure Flexible Microwave Ablation Probe For Lung Nodules",
            "officialTitle": "Feasibility and Efficacy of the AveCure Flexible Microwave Ablation Probe for Peripheral Lung Nodule",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "avecure-flexible-microwave-ablation-probe-for-lung-nodules"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-06-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-02-16",
            "studyFirstSubmitQcDate": "2022-03-11",
            "studyFirstPostDateStruct": {
                "date": "2022-03-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-11-21",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Jason A Beattie",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Beth Israel Deaconess Medical Center"
            },
            "leadSponsor": {
                "name": "Beth Israel Deaconess Medical Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "MedWaves, Inc",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Dana-Farber Cancer Institute",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "This research study to determine the effectiveness of the AveCure Flexible Microwave Ablation Probe to destroy cancerous lung nodules up to 3 c m in size.\n\nThis research study involves microwave ablation (MWA)",
            "detailedDescription": "This will be a single arm, prospective cohort study.\n\nThe names of the study intervention involved in this study is:\n\n* Cone Beam Computed Tomography (CBCT)-guided electromagnetic navigational bronchoscopy (ENB) microwave ablation (MWA)\n* A rapid on-site evaluation (ROSE) will be performed before the MWA to confirm that the lesion is malignant, this can lead to longer procedure time and time under anesthesia.\n\nThe research study procedures include screening for eligibility and study treatment including evaluations and follow up visits.\n\n* Participants will receive the study intervention and will be followed for 30 days.\n* It is expected that about 10 people will take part in this research study.\n\nThis research study is a Pilot Study, which is the first-time investigators are examining this intervention using a bronchoscopic approach for microwave ablation of solitary pulmonary nodules.\n\nThe U.S. Food and Drug Administration (FDA) has approved this intervention as a treatment option for this disease."
        },
        "conditionsModule": {
            "conditions": [
                "Stage I - II Primary Lung Cancer",
                "Stage I Lung Cancer",
                "Stage II Lung Cancer",
                "Lung Cancer Stage I",
                "Lung Cancer Stage II",
                "Lung Cancer"
            ],
            "keywords": [
                "Stage I - II primary lung cancer",
                "Stage I Lung Cancer",
                "Stage II Lung Cancer",
                "Lung Cancer Stage I",
                "Lung Cancer Stage II",
                "Lung Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 10,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "AVECURE FLEXIBLE MICROWAVE ABLATION PROBE FOR LUNG NODULES",
                    "type": "EXPERIMENTAL",
                    "description": "The research study procedures include screening for eligibility and study treatment including evaluations and follow up visits.\n\n* Ablation Procedure- MWA will be used to treat solitary pulmonary nodules up to 3cm.\n* CT scan will then be performed to evaluate the radiological changes 2 - 4 weeks after the ablation procedure.\n* Surgery will be performed to remove the lung nodule and the tissue will be evaluated by pathology.",
                    "interventionNames": [
                        "Device: AveCure 16 Gauge Flexible Microwave Ablation Probe"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "AveCure 16 Gauge Flexible Microwave Ablation Probe",
                    "description": "Microwave ablation of the solitary pulmonary nodule will be performed through a bronchoscopic approach using the AveCure Flexible Microwave Ablation Probe before surgery",
                    "armGroupLabels": [
                        "AVECURE FLEXIBLE MICROWAVE ABLATION PROBE FOR LUNG NODULES"
                    ],
                    "otherNames": [
                        "Avecure"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Rate of Planned Ablations.",
                    "description": "Feasibility of performing the procedure as planned in the enrolled patients. At least 9/10 of the planned ablations (90%) can be performed bronchoscopically according to the established protocol.",
                    "timeFrame": "Day 1"
                },
                {
                    "measure": "Pathological changes in the tumor tissue.",
                    "description": "Pathological evaluation of the acute thermal effect produced by the AveCUre 16G-FMAP on targeted malignant solitary lung nodules will be described. The % necrosis, % viable tumor, and % stroma/inflammation present in the targeted nodules after ablation will be described.",
                    "timeFrame": "4 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Histological changes in lung tissue outside the zone of predicted ablation.",
                    "description": "A secondary analysis of the tissue surrounding the treated area will be performed. The % necrosis and of % stroma/inflammation will be described.",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Immune-histochemical changes in the tumor tissue.",
                    "description": "Immune-histochemical evaluation including TTF-1, Napsin-A, p40, or other immune-histochemical assessments will be performed if needed on a per case basis.",
                    "timeFrame": "4 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Subject with Stage I - II primary lung cancer (Solitary nodules up to 3 cm) as defined by previous pathology or ROSE.\n* Pathological proof of target nodule/tumor type and malignancy with specimen considered adequate per institutional laboratory standards\n* Target nodule/tumor which can be accessed via navigational bronchoscopy and confirmed location with cone beam CT scan intra-operatively\n* Resection/surgical candidate (lobectomy or greater)\n* Participants must be at least 22 years old and able to provide consent\n\nExclusion Criteria:\n\n* Subjects in whom flexible bronchoscopy is contraindicated\n* Target nodule \\< 1.0 cm\n* Prior radiation or neo adjuvant chemotherapy of the target nodule/tumor\n* Any comorbidity that the investigator feels would interfere with the safety of the subject or the evaluation of study objectives\n* Pacemaker, implantable cardioverter, or another electronic implantable device\n* Patient cannot tolerate bronchoscopy\n* Patients with coagulopathy\n* Patients in other therapeutic lung cancer studies\n* Subject is pregnant or breastfeeding\n* COVID-19 positive patient at the time of procedure.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "22 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jason Beattie, MD",
                    "role": "CONTACT",
                    "phone": "(617) 632- 8252",
                    "email": "jbeattie@bidmc.harvard.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jason Beattie, MD",
                    "affiliation": "Beth Israel Deaconess Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Beth Israel Deaconess Medical Center",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Adnan Majid, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Mihir S Parikh, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Beattie Jason, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to Sponsor Investigator or designee. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP"
            ],
            "timeFrame": "Data can be shared no earlier than 1 year following the date of publication",
            "accessCriteria": "Contact the Beth Israel Deaconess Medical Center Technology Ventures Office at tvo@bidmc.harvard.edu"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "asFound": "Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}